Literature DB >> 15115532

Variations in registration of skin cancer in the United Kingdom.

R G Goodwin1, S A Holme, D L Roberts.   

Abstract

Cancer registries are used to compare incidences between regions, plan for service provision, and to assess the impact of health interventions. Significant variation in data capture for skin cancers and reporting of results was evident between regional cancer registries in the UK when assessed in 1991. Using a postal questionnaire we sought to document methods of recording skin cancer incidence in the UK in 2000, and to assess if practice has changed from 1991. All UK cancer registries were asked for details of their method of skin cancer case registration and latest available incidence figures. Methodology was assessed against recently implemented national standards. All registries responded to the survey. Sources of data were more uniform than was the case 9 years ago. All registries except one attained national standards for basal cell carcinoma data collection, but only half of the registries attained standards for squamous cell carcinoma. Ten of the 12 correctly recorded numbers of malignant melanomas, but three still failed to record the Breslow thickness or Clarke's level. Wide variation is evident in the recorded incidences for each of the malignancies, and the efficiency at which figures are made available. Thus, although there has been improvement since 1991, variability still exists between UK registries in methods of data capture, the data recorded, and efficiency of data processing in skin cancer registration.

Entities:  

Mesh:

Year:  2004        PMID: 15115532     DOI: 10.1111/j.1365-2230.2004.01523.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  14 in total

1.  De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012.

Authors:  Valentina Mazzucotelli; Pierluca Piselli; Diana Verdirosi; Claudia Cimaglia; Giovanni Cancarini; Diego Serraino; Silvio Sandrini
Journal:  J Nephrol       Date:  2017-03-19       Impact factor: 3.902

2.  National incidence of eyelid cancer in Ireland (2005-2015).

Authors:  Clare Quigley; Sandra Deady; Emily Hughes; Elizabeth McElnea; Lina Zgaga; Shivona Chetty
Journal:  Eye (Lond)       Date:  2019-04-11       Impact factor: 3.775

3.  Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010.

Authors:  John G Muzic; Adam R Schmitt; Adam C Wright; Dema T Alniemi; Adeel S Zubair; Jeannette M Olazagasti Lourido; Ivette M Sosa Seda; Amy L Weaver; Christian L Baum
Journal:  Mayo Clin Proc       Date:  2017-05-15       Impact factor: 7.616

4.  Increases in invasive melanoma in England, 1979-2006, by anatomical site.

Authors:  S C Wallingford; R D Alston; J M Birch; A C Green
Journal:  Br J Dermatol       Date:  2011-08-04       Impact factor: 9.302

5.  RhoB promotes cancer initiation by protecting keratinocytes from UVB-induced apoptosis but limits tumor aggressiveness.

Authors:  Nicolas Meyer; Alexis Peyret-Lacombe; Bruno Canguilhem; Claire Médale-Giamarchi; Kenza Mamouni; Agnese Cristini; Sylvie Monferran; Laurence Lamant; Thomas Filleron; Anne Pradines; Olivier Sordet; Gilles Favre
Journal:  J Invest Dermatol       Date:  2013-06-21       Impact factor: 8.551

6.  Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.

Authors:  Youjin Wang; Ruth M Pfeiffer; Rotana Alsaggaf; Wilhelmine Meeraus; Julia C Gage; Lesley A Anderson; Renée C Bremer; Nikoletta Nikolenko; Hanns Lochmuller; Mark H Greene; Shahinaz M Gadalla
Journal:  Int J Cancer       Date:  2017-11-20       Impact factor: 7.396

7.  Childhood cancer registration in Britain: capture-recapture estimates of completeness of ascertainment.

Authors:  M E Kroll; M F G Murphy; L M Carpenter; C A Stiller
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

8.  Treatment of facial Basal cell carcinoma: a review.

Authors:  Vanessa Smith; Shernaz Walton
Journal:  J Skin Cancer       Date:  2011-04-27

9.  Geography of non-melanoma skin cancer and ecological associations with environmental risk factors in England.

Authors:  B W Wheeler; G Kothencz; A S Pollard
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

10.  The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.

Authors:  Louise K Mercer; Adele C Green; James B Galloway; Rebecca Davies; Mark Lunt; William G Dixon; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2012-01-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.